October 17, 2023
SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease
SpliceBio is eligible to receive upfront, opt-in and milestone payments up to $216 million plus…
Recent Comments